Literature DB >> 12731068

Low-avidity recognition by CD4+ T cells directed to self-antigens.

John A Gebe1, Ben A Falk, Kellee A Rock, Sharon A Kochik, Anne K Heninger, Helena Reijonen, William W Kwok, Gerald T Nepom.   

Abstract

Self-reactive T cells populate the peripheral immune system, and likely form the reservoir from which autoreactive cells are derived. We analyzed a panel of self and non-self peptides presented by HLA-DR4, a class II molecule associated with autoimmunity, by immunization of mice transgenic for HLA-DR4. Significant structural avidity for T cell recognition, as measured by MHC class II tetramer binding to CD4(+) T cells was only observed in mice immunized with the non-self antigens. T cell hybridomas were generated from mice immunized with the naturally processed self-peptide hGAD65 (552-572) and also from mice immunized with an influenza-derived non-self epitope (HA 306-318). T cells specific for the self peptide failed to bind tetramers and exhibited low functional avidity as measured by the peptide concentration required to reach half-maximum proliferation values. In contrast, T cells specific for the non-self HA (306-318) peptide exhibited high structural and functional avidity profiles. As recently described in studies of murine CD8(+) T cell function, the predominance of low avidity recognition of self-peptide epitopes may be a characteristic feature of CD4(+) T cells responding to autoantigens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12731068     DOI: 10.1002/eji.200323871

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  30 in total

1.  Persistent viral infection in humans can drive high frequency low-affinity T-cell expansions.

Authors:  Naeem Khan; Mark Cobbold; Joanne Cummerson; Paul A H Moss
Journal:  Immunology       Date:  2010-08-16       Impact factor: 7.397

Review 2.  Targeting T lymphocytes for immune monitoring and intervention in autoimmune diabetes.

Authors:  Roberto Mallone; Gerald T Nepom
Journal:  Am J Ther       Date:  2005 Nov-Dec       Impact factor: 2.688

3.  Use of multiple peptides containing T cell epitopes is a feasible approach for peptide-based immunotherapy in Can f 1 allergy.

Authors:  Anu K Immonen; Antti H Taivainen; Ale T O Närvänen; Tuure T Kinnunen; Soili A Saarelainen; Marja A Rytkönen-Nissinen; Tuomas I Virtanen
Journal:  Immunology       Date:  2007-01       Impact factor: 7.397

Review 4.  Class II major histocompatibility complex tetramer staining: progress, problems, and prospects.

Authors:  Sabrina S Vollers; Lawrence J Stern
Journal:  Immunology       Date:  2008-03       Impact factor: 7.397

5.  Regulatory and T Effector Cells Have Overlapping Low to High Ranges in TCR Affinities for Self during Demyelinating Disease.

Authors:  Jennifer D Hood; Veronika I Zarnitsyna; Cheng Zhu; Brian D Evavold
Journal:  J Immunol       Date:  2015-09-18       Impact factor: 5.422

6.  On-chip activation and subsequent detection of individual antigen-specific T cells.

Authors:  Qing Song; Qing Han; Elizabeth M Bradshaw; Sally C Kent; Khadir Raddassi; Björn Nilsson; Gerald T Nepom; David A Hafler; J Christopher Love
Journal:  Anal Chem       Date:  2010-01-15       Impact factor: 6.986

Review 7.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

8.  Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.

Authors:  Seon-Kyeong Kim; Kristin V Tarbell; Maija Sanna; Mary Vadeboncoeur; Tibor Warganich; Mark Lee; Mark Davis; Hugh O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-20       Impact factor: 11.205

9.  Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses.

Authors:  Takumi Kumai; Sujin Lee; Hyun-Il Cho; Hussein Sultan; Hiroya Kobayashi; Yasuaki Harabuchi; Esteban Celis
Journal:  Cancer Immunol Res       Date:  2016-12-09       Impact factor: 11.151

10.  Functional islet-specific Treg can be generated from CD4+CD25- T cells of healthy and type 1 diabetic subjects.

Authors:  S Alice Long; Mindi R Walker; Mary Rieck; Eddie James; William W Kwok; Srinath Sanda; Catherine Pihoker; Carla Greenbaum; Gerald T Nepom; Jane H Buckner
Journal:  Eur J Immunol       Date:  2009-02       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.